ABBOTT LABORATORIES — Director's Dealing 2012

Aug 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-07-30

Reporting Person: LINDER GREG W (Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-30	Common shares without par value	M	14991	$52.55	Acquired	142541	Direct
2012-07-30	Common shares without par value	M	5565	$52.49	Acquired	148106	Direct
2012-07-30	Common shares without par value	F	18043	$66.39	Disposed	130063	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-30	Option (right to buy)	$52.55	M	14991	Disposed	2014-02-19	Common shares (14991)	Direct
2012-07-30	Option (right to buy)	$52.49	M	5565	Disposed	2014-02-19	Common shares (5565)	Direct
2012-07-30	Option (right to buy)	$66.39	A	18043	Acquired	2014-02-19	Common shares (18043)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	4054	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 30, 2012.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.